Inhibikase Therapeutics (IKT) Files $300M Mixed Shelf
Tweet
Share
E-mailGet Alerts IKT Hot Sheet
Join SI Premium – FREE
Inhibikase Therapeutics (NASDAQ: IKT) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Expected to Tell Investors It Sees a More Than $30T Total Addressable Market - WSJ
- Kohl's (KSS) call put ratio 1 call to 2.1 puts into quarter results
- XPeng (XPEV) PT Lowered to $22 at Freedom Broker
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
